TENAX THERAPEUTICS, INC. (29)
Browse by Contract Category
Contracts
-
CONSULTING AGREEMENT
(Filed With SEC on November 15, 2021)
-
Plan for Employee Inducement Stock Options adopted July 6, 2021 with Form of Stock Option Agreement
(Filed With SEC on July 8, 2021)
-
Agreement and Plan of Merger among PHPrecisionMed Inc., Tenax Therapeutics, Inc., Life Newco II, Inc., and Dr. Stuart Rich dated January 15, 2021
(Filed With SEC on January 19, 2021)
-
Amendment to License Agreement, dated as of October 9, 2020, by and between Tenax Therapeutics, Inc. and Orion Corporation
(Filed With SEC on October 15, 2020)
-
SEPARATION AND RELEASE AGREEMENT
(Filed With SEC on November 15, 2021)
-
CONSULTING AGREEMENT
(Filed With SEC on November 15, 2021)
-
Amendment No. 2 to 2016 Stock Incentive Plan
(Filed With SEC on August 16, 2021)
-
Executive Employment Agreement with Christopher T. Giordano dated July 6, 2021
(Filed With SEC on July 8, 2021)
-
Separation and General Release Agreement with Anthony A. DiTonno dated July 6, 2021
(Filed With SEC on July 8, 2021)
-
Registration Rights Agreement dated as of July 6, 2021 by and between the Company and the Investor
(Filed With SEC on July 8, 2021)
-
Securities Purchase Agreement for Unregistered Pre-Funded Warrant, dated as of July 6, 2021 by and between the Company and the Investor
(Filed With SEC on July 8, 2021)
-
Form of HCW Warrant (2021)
(Filed With SEC on July 8, 2021)
-
Form of Unregistered Warrant (2021)
(Filed With SEC on July 8, 2021)
-
Form of Unregistered Pre-Funded Warrant (2021)
(Filed With SEC on July 8, 2021)
-
Description of Common Stock
(Filed With SEC on March 31, 2021)
-
Employment Agreement with Dr. Stuart Rich dated January 15, 2021
(Filed With SEC on January 19, 2021)
-
Certificate of Designation of Series B Convertible Preferred Stock
(Filed With SEC on January 19, 2021)
-
Form of Registration Rights Agreement, dated as of July 6, 2020, by and between the Company and the Investor
(Filed With SEC on July 8, 2020)
-
Form of Securities Purchase Agreement for Class E Units and Class F Units, dated as of July 6, 2020, by and between the Company and the Investor
(Filed With SEC on July 8, 2020)
-
Form of Securities Purchase Agreement for Class C Units and Class D Units, dated as of July 6, 2020, by and between the Company and the Investor
(Filed With SEC on July 8, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on July 8, 2020)
-
Form of Unregistered Warrant
(Filed With SEC on July 8, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on July 8, 2020)
-
Note, dated April 30, 2020, between Tenax Therapeutics, Inc. and First Horizon Bank
(Filed With SEC on May 15, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 13, 2020)
-
Form of Securities Purchase Agreement, dated as of March 11, 2020, by and between the Company and the Investor
(Filed With SEC on March 13, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on March 13, 2020)
-
Form of Unregistered Warrant
(Filed With SEC on March 13, 2020)
-
Amendment No. 1 to 2016 Stock Incentive Plan
(Filed With SEC on August 14, 2019)
